Molly A. Silvers

Statistics

Publications

Citations

640

H-Index

Active since

2014

Affiliations

The University of Texas Southwestern Medical Center(Current)

Louisiana State University

University of Florida

Southwestern Medical Center

Molly A. Silvers is an author at The University of Texas Southwestern Medical Center specializing in molecular oncology, enzyme inhibition, and oncology.

ORCID

Publications per year

2014–2017

Publications

A member of the Phosphate transporter 1 (Pht1) family from the arsenic‐hyperaccumulating fern <i>Pteris vittata</i> is a high‐affinity arsenate transporter

Sandra Feuer DiTusa, Elena B. Fontenot, Robert W. Wallace et al. · New Phytologist · 2015 · 179 citations · Full text

Agriculture, Plant Biology, Plant Sciences +12

Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors

Xiumei Huang, Edward A. Motea, Zachary Moore et al. · Cancer Cell · 2016 · 132 citations · Full text

Medicine, Oncology, Pharmacology +12

The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism

Molly A. Silvers, Naveen Singh, Robert A. Egnatchik et al. · Journal of Biological Chemistry · 2017 · 95 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights

Eduardo H. G. da Cruz, Molly A. Silvers, Guilherme A. M. Jardim et al. · European Journal of Medicinal Chemistry · 2016 · 80 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +13

Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone

Gaurab Chakrabarti, Molly A. Silvers, Mariya Ilcheva et al. · Scientific Reports · 2015 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 8